Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis.

On comparison with the mIgG2a isotype control, 58A2 reduced spleen and BM fibrosis measured on day 34 in MPL W508A mice, although this did not reach statistical significance ( Figure 2 A).

also in 111,027 other papers